Imaging in the era of risk-adapted treatment in Colon cancer

Max J Lahaye*, Doenja M J Lambregts, Arend G J Aalbers, Petur Snaebjornsson, R G H Beets-Tan, Niels F M Kok

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The treatment landscape for patients with colon cancer is continuously evolving. Risk-adapted treatment strategies, including neoadjuvant chemotherapy and immunotherapy, are slowly finding their way into clinical practice and guidelines. Radiologists are pivotal in guiding clinicians toward the most optimal treatment for each colon cancer patient. This review provides an overview of recent and upcoming advances in the diagnostic management of colon cancer and the radiologist's role in the multidisciplinary approach to treating colon cancer.

Original languageEnglish
JournalBritish Journal of Radiology
Volume97
Issue number1159
Pages (from-to)1214-1221
ISSN0007-1285
DOIs
Publication statusPublished - Jul 2024

Bibliographical note

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology. All rights reserved. For permissions, please email: [email protected].

Keywords

  • Colonic Neoplasms/diagnostic imaging
  • Humans
  • Immunotherapy/methods
  • Neoadjuvant Therapy/methods
  • Risk Assessment

Fingerprint

Dive into the research topics of 'Imaging in the era of risk-adapted treatment in Colon cancer'. Together they form a unique fingerprint.

Cite this